Article Details
Retrieved on: 2021-06-30 21:45:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The inventors in that case developed numerous lines of monoclonal antibodies capable of binding to the proprotein convertase subtilisin/kexin type 9 (“ ...
Article found on: www.natlawreview.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here